Compare LYRA & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYRA | ASTC |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.9M |
| IPO Year | 2020 | 1995 |
| Metric | LYRA | ASTC |
|---|---|---|
| Price | $3.47 | $3.74 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 35.1K | ★ 133.0K |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $600,000.00 | ★ $1,312,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $93.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.06 |
| 52 Week Low | $2.84 | $2.47 |
| 52 Week High | $37.50 | $8.01 |
| Indicator | LYRA | ASTC |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 52.50 |
| Support Level | $3.51 | $3.43 |
| Resistance Level | $4.04 | $3.91 |
| Average True Range (ATR) | 0.33 | 0.40 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 39.62 | 43.74 |
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.